Vanguard Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Vanguard Asset Management's PFE Position: Q3 2026 in Review
Vanguard Asset Management increased its Pfizer (PFE) stake by 7.7% in Q3 2026, buying an estimated $26.5M and bringing the position to 13,870,224 shares worth $396M. The position accounts for 0.24% of the portfolio, ranked #70.
Vanguard Asset Management first reported a position in PFE in Q1 2026 and has held it in 3 quarters since. 2,796 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Vanguard Asset Management held 13,870,224 shares of Pfizer worth $396M as of Q3 2026.
- Vanguard Asset Management bought 994,960 Pfizer shares in Q3 2026, an estimated $26.5M.
- Pfizer made up 0.24% of Vanguard Asset Management's portfolio in Q3 2026, its #70 holding.
- Vanguard Asset Management first reported a position in Pfizer in Q1 2026 and has held it in 3 quarters since.
- 2,796 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.